Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 7, 2014, Pages 963-969

  Turlo, Kirsten ^a   Leung, Calvin S ^a   Seo, Jane J ^a   Goulbourne, Chris N ^a   Adeyo, Oludotun ^a   Gin, Peter ^a   Voss, Constance ^a   Bensadoun, André ^b   Fong, Loren G ^a   Young, Stephen G ^a,c   Beigneux, Anne P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GPIHBP1; Lipoprotein lipase; Triglyceride metabolism

Indexed keywords

AGAROSE; CELL EXTRACT; CELL PROTEIN; GPIHBP1 PROTEIN; LIPOPROTEIN LIPASE; S447X LPL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; CELL ASSAY; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPRESSION VECTOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN POLYMORPHISM; SITE DIRECTED MUTAGENESIS; STOP CODON; WESTERN BLOTTING;

GPIHBP1; LIPOPROTEIN LIPASE; TRIGLYCERIDE METABOLISM;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BIOLOGICAL ASSAY; CHO CELLS; CRICETULUS; GENE EXPRESSION; HUMANS; IMMOBILIZED PROTEINS; LIPID METABOLISM; LIPOPROTEIN LIPASE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, LIPOPROTEIN; RECOMBINANT FUSION PROTEINS; TRIGLYCERIDES;

EID: 84899496751     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.03.011     Document Type: Article

References (39)

1. E.D. Korn Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart J. Biol. Chem. 215 1955 1 14
2. E.D. Korn Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil J. Biol. Chem. 215 1955 15 26
3. S.G. Young, and R. Zechner Biochemistry and pathophysiology of intravascular and intracellular lipolysis Genes Dev. 27 2013 459 484
4. J.D. Brunzell, and S.S. Deeb Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, K.W. Kinzler, B. Vogelstein, The Metabolic and Molecular Bases of Inherited Disease vol. 2 2001 McGraw-Hill New York 2789 2816
5. C.T. Johansen, and R.A. Hegele Genetic bases of hypertriglyceridemic phenotypes Curr. Opin. Lipidol. 22 2011 247 253
6. B.G. Nordestgaard, S. Abildgaard, H.H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjaerg-Hansen Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease Circulation 96 1997 1737 1744
7. M.E. Wittekoek, E. Moll, S.N. Pimstone, M.D. Trip, P.J. Lansberg, J.C. Defesche, J.J. van Doormaal, M.R. Hayden, and J.J. Kastelein A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 19 1999 2708 2713
8. J.J. Kastelein, J.M. Ordovas, M.E. Wittekoek, S.N. Pimstone, W.F. Wilson, S.E. Gagne, M.G. Larson, E.J. Schaefer, J.M. Boer, C. Gerdes, and M.R. Hayden Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women Clin. Genet. 56 1999 297 305
9. A. Chait, J.J. Albers, and J.D. Brunzell Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia Eur. J. Clin. Invest. 10 1980 17 22
10. J.D. Horton, H. Shimano, R.L. Hamilton, M.S. Brown, and J.L. Goldstein Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL J. Clin. Invest. 103 1999 1067 1076
11. J.M. MacArthur, J.R. Bishop, K.I. Stanford, L. Wang, A. Bensadoun, J.L. Witztum, and J.D. Esko Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members J. Clin. Invest. 117 2007 153 164
12. U. Beisiegel, A. Krapp, W. Weber, G. Olivecrona, and J. Gliemann The role of lipases and LRP in the catabolism of triglyceride-rich lipoproteins Z. Gastroenterol. 34 Suppl. 3 1996 108 109
13. C.V. Voss, B.S. Davies, S. Tat, P. Gin, L.G. Fong, C. Pelletier, C.D. Mottler, A. Bensadoun, A.P. Beigneux, and S.G. Young Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1 Proc. Natl. Acad. Sci. U. S. A. 108 2011 7980 7984
14. N. Skottova, R. Savonen, A. Lookene, M. Hultin, and G. Olivecrona Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver J. Lipid Res. 36 1995 1334 1344
15. J. Rip, M.C. Nierman, C.J. Ross, J.W. Jukema, M.R. Hayden, J.J. Kastelein, E.S. Stroes, and J.A. Kuivenhoven Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation Arterioscler. Thromb. Vasc. Biol. 26 2006 1236 1245
16. S.E. Gagne, M.G. Larson, S.N. Pimstone, E.J. Schaefer, J.J. Kastelein, P.W. Wilson, J.M. Ordovas, and M.R. Hayden A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study Clin. Genet. 55 1999 450 454
17. G. Ranganathan, R. Unal, I.D. Pokrovskaya, P. Tripathi, J.I. Rotter, M.O. Goodarzi, and P.A. Kern The lipoprotein lipase (LPL) S447X gain of function variant involves increased mRNA translation Atherosclerosis 221 2012 143 147
18. L. Previato, O. Guardamagna, J.D. Brunzell, S. Santamarina-Fojo, and H.B. Brewer Jr. A novel missense mutation in the C-terminal domain of lipoprotein lipase leads to enzyme inactivation Circulation vol. 86 1992 I-608
19. K. Kozaki, T. Gotoda, M. Kawamura, H. Shimano, Y. Yazaki, Y. Ouchi, H. Orimo, and N. Yamada Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation J. Lipid Res. 34 1993 1765 1772
20. H. Zhang, H. Henderson, S.E. Gagne, S.M. Clee, L. Miao, G. Liu, and M.R. Hayden Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function Biochim. Biophys. Acta 1302 1996 159 166
21. S. Salinelli, J.Y. Lo, M.P. Mims, E. Zsigmond, L.C. Smith, and L. Chan Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center J. Biol. Chem. 271 1996 21906 21913
22. F. Faustinella, A. Chang, J.P. Van Biervliet, M. Rosseneu, N. Vinaimont, L.C. Smith, S.H. Chen, and L. Chan Catalytic triad residue mutation (Asp156 - Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447 - Ter) in a Turkish family J. Biol. Chem. 266 1991 14418 14424
23. C.J. Ross, G. Liu, J.A. Kuivenhoven, J. Twisk, J. Rip, W. van Dop, K.J. Excoffon, S.M. Lewis, J.J. Kastelein, and M.R. Hayden Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation Arterioscler. Thromb. Vasc. Biol. 25 2005 2143 2150
24. B.S.J. Davies, A.P. Beigneux, R.H. Barnes II, Y. Tu, P. Gin, M.M. Weinstein, C. Nobumori, R. Nyrén, I.J. Goldberg, G. Olivecrona, A. Bensadoun, S.G. Young, and L.G. Fong GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries Cell Metab. 12 2010 42 52
25. M.M. Weinstein, L. Yin, A.P. Beigneux, B.S. Davies, P. Gin, K. Estrada, K. Melford, J.R. Bishop, J.D. Esko, G.M. Dallinga-Thie, L.G. Fong, A. Bensadoun, and S.G. Young Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice J. Biol. Chem. 283 2008 34511 34518
26. G. Olivecrona, E. Ehrenborg, H. Semb, E. Makoveichuk, A. Lindberg, M.R. Hayden, P. Gin, B.S. Davies, M.M. Weinstein, L.G. Fong, A.P. Beigneux, S.G. Young, T. Olivecrona, and O. Hernell Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia J. Lipid Res. 51 2010 1535 1545
27. A. Onat, G. Hergenc, M. Agirbasli, Z. Kaya, G. Can, and N.E. Unaltuna Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking Clin. Chem. Lab. Med. 47 2009 208 215
28. A.P. Beigneux, P. Gin, B.S.J. Davies, M.M. Weinstein, A. Bensadoun, L.G. Fong, and S.G. Young Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase J. Biol. Chem. 284 2009 30240 30247
29. R. Franssen, S.G. Young, F. Peelman, J. Hertecant, J.A. Sierts, A.W.M. Schimmel, A. Bensadoun, J.J.P. Kastelein, L.G. Fong, G.M. Dallinga-Thie, and A.P. Beigneux Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects Circ. Cardiovasc. Genet. 3 2010 169 178
30. M. van Hoek, G.M. Dallinga-Thie, E.W. Steyerberg, and E.J. Sijbrands Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes Eur. J. Hum. Genet. 17 2009 1386 1393
31. H.E. Henderson, J.J. Kastelein, A.H. Zwinderman, E. Gagne, J.W. Jukema, P.W. Reymer, B.E. Groenemeyer, K.I. Lie, A.V. Bruschke, M.R. Hayden, and H. Jansen Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins J. Lipid Res. 40 1999 735 743
32. A.P. Beigneux, B. Davies, P. Gin, M.M. Weinstein, E. Farber, X. Qiao, P. Peale, S. Bunting, R.L. Walzem, J.S. Wong, W.S. Blaner, Z.M. Ding, K. Melford, N. Wongsiriroj, X. Shu, F. de Sauvage, R.O. Ryan, L.G. Fong, A. Bensadoun, and S.G. Young Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons Cell Metab. 5 2007 279 291
33. K.A. Dugi, H.L. Dichek, and S. Santamarina-Fojo Human hepatic and lipoprotein lipase: the loop covering the catalytic site mediates lipase substrate specificity J. Biol. Chem. 270 1995 25396 25401
34. M.S. Liu, Y. Ma, M.R. Hayden, and J.D. Brunzell Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity Biochim. Biophys. Acta 1128 1992 113 115
35. J. Peterson, W.Y. Fujimoto, and J.D. Brunzell Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies J. Lipid Res. 33 1992 1165 1170
36. P.H. Weinstock, C.L. Bisgaier, K. Aalto-Setälä, H. Radner, R. Ramakrishnan, S. Levak-Frank, A.D. Essenburg, R. Zechner, and J.L. Breslow Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes J. Clin. Invest. 96 1995 2555 2568
37. P. Gin, A.P. Beigneux, C. Voss, B.S. Davies, J.A. Beckstead, R.O. Ryan, A. Bensadoun, L.G. Fong, and S.G. Young Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells Arterioscler. Thromb. Vasc. Biol. 31 2011 176 182
38. P. Gin, L. Yin, B.S. Davies, M.M. Weinstein, R.O. Ryan, A. Bensadoun, L.G. Fong, S.G. Young, and A.P. Beigneux The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons J. Biol. Chem. 284 2008 29554 29562
39. P. Gin, C.N. Goulbourne, O. Adeyo, A.P. Beigneux, B.S. Davies, S. Tat, C.V. Voss, A. Bensadoun, L.G. Fong, and S.G. Young Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1 Hum. Mol. Genet. 21 2012 2961 2972